Home / Drug shortages / Everolimus Tablet

Everolimus Tablet — FDA Drug Shortage

To Be Discontinued — Endo Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Everolimus Tablet (tablet) from Endo Pharmaceuticals, Inc. with status To Be Discontinued. The shortage was first posted on 01/06/2026.

Shortage Details

Status
To Be Discontinued
Company
Endo Pharmaceuticals, Inc.
Package NDC
49884-125-91
Dosage Form
Tablet
Presentation
Everolimus, Tablet, 5 mg (NDC 49884-125-91)
Initial Posting
01/06/2026
Revised Date

FDA data resources